Canephron N oral drops bottle 100 ml

Instructions for Canephron N oral drops, 100 ml bottle

Composition

active ingredients: 100 g of drops contain 29 g of extract (1:16) (extractant ethanol 59% (v/v) from medicinal plants:

Centaury herb (Nerba Centauria) 0.6 g

lovage root (Rаdіх Lеvіstісі) 0.6 g

rosemary leaves (Folia Rosmarini) 0.6 g;

excipient: purified water.

Ethanol content - 19% (v/v).

Dosage form

Oral drops.

Main physicochemical properties: clear or slightly cloudy yellow-brown liquid with a lovage odor and an aromatic, slightly bitter taste.

During storage, cloudiness or precipitation may occur.

Pharmacotherapeutic group

Drugs used in urology. ATX code G04B X.

Pharmacological properties

Pharmacodynamics

The components that make up the herbal medicine exhibit complex activity, which is manifested in anti-inflammatory, antioxidant, antispasmodic and analgesic effects. Kanefronâ N also has antibacterial and diuretic effects, which are due to the substances contained in the herbal components of the drug.

Indication

For the complex treatment of inflammatory diseases of the urinary tract. Prevention of the formation of urinary stones, including after their removal.

Contraindication

Hypersensitivity to any component of the drug or to other plants of the Apiaceae family, such as anise, fennel, and anethole (i.e. a component of essential oils containing, for example, anise and fennel). Peptic ulcer in the acute stage. Edema due to heart failure or impaired renal function and/or reduced fluid intake has been recommended.

Interaction with other medicinal products and other types of interactions

If it is necessary to use any other medicines at the same time, you should consult a doctor.

Application features

During storage, the drug may become cloudy or precipitate, but this does not affect the effect of the drug.

In case of prolonged fever, cramps, blood in the urine, urination disorders, and acute urinary retention, you should immediately consult a doctor.

This medicinal product contains 19% ethanol. The medicinal product should not be taken by patients suffering from alcoholism or by patients who have completed treatment for alcoholism. The alcohol content of the medicinal product should be taken into account when used in patients at high risk, such as those with liver disease, epilepsy, or brain disease.

Ability to influence reaction speed when driving vehicles or other mechanisms

The drug in recommended doses does not affect the ability to drive and operate other mechanisms, but it should be borne in mind that the drug contains ethanol.

Use during pregnancy or breastfeeding

Pregnancy

No experimental negative results of direct or indirect effects of the drug have been identified. Currently, there is limited experience with the use of Canephron H drops in pregnant women. Therefore, for safety reasons, the use of the drug during pregnancy should be avoided.

Breast-feeding

Due to the lack of data on the excretion of Canephron H or its metabolites into breast milk, a risk to infants cannot be excluded. Therefore, the drug should not be used during breastfeeding.

Method of administration and doses

Unless otherwise prescribed by a doctor, the drug should be taken by adults and children over 12 years of age, 50 drops 3 times a day (total daily dose - 150 drops).

Adults usually take the drops undiluted. If necessary (for example: bitter taste for children), take the drops with the addition of any liquid. Shake before use! When instilling the drug, the bottle should be held vertically.

While taking the drug, it is necessary to ensure the consumption of sufficient amounts of fluid.

The duration of treatment is determined by the doctor individually. If the drug is well tolerated, it can be prescribed for a long period.

Children

The drug should not be used in children under 12 years of age.

Overdose

Cases of drug poisoning due to overdose are unknown.
Therapy: symptomatic.

Adverse reactions

Gastrointestinal disturbances (nausea, vomiting, diarrhea) are common. Allergic reactions may occur in case of hypersensitivity to the components of the drug, including rash, urticaria, itching, and skin hyperemia.

If any adverse reactions occur, discontinue use of the drug and consult a doctor.

Expiration date

2 years.

After first opening the bottle, the drug is suitable for use for 6 months.

Do not use the drug after the expiration date indicated on the package.

The expiration date determines the use of the drug until the last day of the month.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C, out of the reach of children.

Packaging

100 ml in a bottle in a cardboard box.

Vacation category

Without a prescription.

Producer

Bionorica CE.

Location of the manufacturer and its business address

Kerchensteinerstrasse, 11-15, 92318, Neumarkt, Germany.